Literature DB >> 8224350

Biochemistry of porphyria.

M R Moore1.   

Abstract

1. The porphyrias are a group of metabolic disorders arising from defects in the haem biosynthetic pathway. Most forms are inherited as Mendelian autosomal dominants, but some types are recessive and others acquired through exposure to porphyrinogenic drugs and chemicals. There is a linked group of diseases, which are not porphyrias, but have in common alterations of haem biosynthesis. 2. The processes of haem biosynthesis are now well understood and the molecular biology of the functions and dysfunctions in the porphyrias are currently an area of intensive investigation. 3. The acute porphyrias, Acute Intermittent Porphyria, Variegate Porphyria and Hereditary Coproporphyria are of most importance since attacks of these may be life-threatening. 4. These diseases that usually present with a neurovisceral attack are characterized by excess production of the porphyrin precursors, 5-aminolaevulinate and porphobilinogen because of lowered activity of Porphobilinogen deaminase. 5. A variety of factors may precipitate these attacks including various drugs, alcohol, smoking, dieting or fasting and variations in steroid hormone levels. 6. The non-acute porphyrias are largely dermatological conditions, which present clinically as cutaneous photosensitivity. The dermatological changes are caused by the photosensitizing properties of circulating porphyrins and are accompanied by systemic effects of these porphyrins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224350     DOI: 10.1016/0020-711x(93)90683-6

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  14 in total

1.  Tetrapyrrole Metabolism in Arabidopsis thaliana.

Authors:  Ryouichi Tanaka; Koichi Kobayashi; Tatsuru Masuda
Journal:  Arabidopsis Book       Date:  2011-07-31

2.  Gametophyte Development Needs Mitochondrial Coproporphyrinogen III Oxidase Function.

Authors:  Pritu Pratibha; Sunil Kumar Singh; Ramamurthy Srinivasan; Shripad Ramachandra Bhat; Yelam Sreenivasulu
Journal:  Plant Physiol       Date:  2017-03-07       Impact factor: 8.340

3.  Porphyria and vampirism: another myth in the making.

Authors:  A M Cox
Journal:  Postgrad Med J       Date:  1995-11       Impact factor: 2.401

Review 4.  [Hepatic porphyrias and alcohol].

Authors:  M O Doss; A Kühnel; U Gross; I Sieg
Journal:  Med Klin (Munich)       Date:  1999-06-15

5.  5-Aminolaevulinate synthase gene promoter contains two cAMP-response element (CRE)-like sites that confer positive and negative responsiveness to CRE-binding protein (CREB).

Authors:  L E Giono; C L Varone; E T Cánepa
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

Review 6.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 7.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 8.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

9.  Increased expression of Fe-chelatase leads to increased metabolic flux into heme and confers protection against photodynamically induced oxidative stress.

Authors:  Jin-Gil Kim; Kyoungwhan Back; Hyoung Yool Lee; Hye-Jung Lee; Thu-Ha Phung; Bernhard Grimm; Sunyo Jung
Journal:  Plant Mol Biol       Date:  2014-07-19       Impact factor: 4.076

10.  Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.

Authors:  H Puy; J C Deybach; A Bogdan; J Callebert; M Baumgartner; P Voisin; Y Nordmann; Y Touitou
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.